FDA Clearance Tracker · K242453
Terragene® Bionova® Photon Process Challenge Device with unique-point integrator (PCD225-2);Terragene® Bionova® Photon Process Challenge Device with moving-front integrator (PCD225-C)
Last checked: Nov 19, 2026Latest source record: Dec 12, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Dec 12, 2024
Substantially Equivalent
Time to decision
115 days
Received Aug 19, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K242453
- Device name
- Terragene® Bionova® Photon Process Challenge Device with unique-point integrator (PCD225-2);Terragene® Bionova® Photon Process Challenge Device with moving-front integrator (PCD225-C)
- Applicant
- Terragene S.A.
- Applicant location
- Alvear, AR
- Received
- Aug 19, 2024
- Decided
- Dec 12, 2024
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 880.2800
- Specialty
- Hospital Medicine & Nursing
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code FRC. The earliest in FDA's data is K761015, decided Jan 21, 1977.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K242453
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Terragene S.A.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K231383 · Decided Sep 18, 2024 · 495 days after receipt
Device type: Indicator, Biological Sterilization Process (FRC) · Hospital Medicine & Nursing
- Terragene Bionova Photon Biological Indicator (BT225); Terragene Bionova Photon Auto-Reader Incubator (BPH)New device typeDe Novo
DEN220042 · Decided Jul 12, 2024 · 742 days after receipt
Device type: Biological Sterilization Indicator With Indirect Growth Detection (QVB) · Hospital Medicine & Nursing
K232103 · Decided Apr 5, 2024 · 266 days after receipt
Device type: A Chemical Vapor Sterilization Multivariable Chemical Indicator (QKM) · Hospital Medicine & Nursing
4 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.